2026-04-14T06:02:01Zhttps://recercat.cat/oai/request

oai:recercat.cat:11351/121562025-10-24T10:36:43Zcom_2072_378070com_2072_378040col_2072_378092

Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL Minga, Eva Chamou, Dimitra Kotaskova, Jana Chatzikonstantinou, Thomas Scarfo', Lydia KARAKATSOULIS, GEORGIOS Bosch, Francesc IACOBONI, GLORIA Institut Català de la Salut [Chatzikonstantinou T, Minga E, Karakatsoulis G, Chamou D] Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece. [Scarfò L] Università Vita‐Salute San Raffaele, Milan, Italy. IRCCS Ospedale San Raffaele, Milan, Italy. [Kotaskova J] Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic. Department of Internal Medicine‐Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic. [Iacoboni G, Bosch F] Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain Vall d'Hebron Barcelona Hospital Campus Leucèmia limfocítica crònica - Tractament Proteïnes quinases - Inhibidors - Ús terapèutic CHEMICALS AND DRUGS::Enzymes and Coenzymes::Enzymes::Transferases::Phosphotransferases::Phosphotransferases (Alcohol Group Acceptor)::Protein Kinases::Protein-Tyrosine Kinases Other subheadings::Other subheadings::Other subheadings::/antagonists & inhibitors DISEASES::Neoplasms::Neoplasms by Histologic Type::Leukemia::Leukemia, Lymphoid::Leukemia, B-Cell::Leukemia, Lymphocytic, Chronic, B-Cell Other subheadings::Other subheadings::Other subheadings::/drug therapy COMPUESTOS QUÍMICOS Y DROGAS::enzimas y coenzimas::enzimas::transferasas::fosfotransferasas::fosfotransferasas (grupo alcohol aceptor)::proteína cinasas::proteína-tirosina cinasas Otros calificadores::Otros calificadores::Otros calificadores::/antagonistas & inhibidores ENFERMEDADES::neoplasias::neoplasias por tipo histológico::leucemia::leucemia linfoide::leucemia de células B::leucemia linfocítica crónica de células B Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia Therapeutic strategies; Chronic lymphocytic leukemia Estrategias terapéuticas; Leucemia linfocítica crónica Estratègies terapèutiques; Leucèmia limfocítica crònica This project was supported in part by AbbVie; AIRC under 5 per Mille 2018-ID. 21198 program (to PG and GG); PNRR-MAD-2022-12375673 (Next Generation EU, M6/C2_CALL 2022), Italian Ministry of Health, Rome, Italy, Conceptual development of research organization (FNBr 65269705) provided by the Ministry of Health of the Czech Republic, and National Institute for Cancer Research (Programme EXCELLES, ID Project No. LX22NPO5102) funded by the European Union—Next Generation EU. 2024-10-30T11:50:15Z 2024-10-30T11:50:15Z 2024-09-17 info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Chatzikonstantinou T, Scarfò L, Minga E, Karakatsoulis G, Chamou D, Kotaskova J, et al. Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL. HemaSphere. 2024 Sep;8(9):e70004. 2572-9241 https://hdl.handle.net/11351/12156 10.1002/hem3.70004 39290716 001314048700001 http://hdl.handle.net/11351/12156 eng HemaSphere;8(9) https://doi.org/10.1002/hem3.70004 Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ info:eu-repo/semantics/openAccess application/pdf Wiley Scientia